Edit |   |
---|---|
Antigenic Specificity | HERV & RSV Envelope Protein, Human (Temelimab biosimilar) |
Clone | Temelimab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human HERV & RSV Envelope Protein Recombinant Antibody. The first Chinese-made PD-1 monoclonal antibody, developed by Suzhou Zhonghe Bio, a company of Junshi Bio, was conditionally approved by the State Drug Administration (NMPA) of China in December 2018 for the treatment of locally progressive or metastatic melanoma after failure of previous standard therapy. |
Immunogen | n/a |
Other Names | Anti-HERV & RSV Envelope Protein Recombinant Antibody, Research Grade Temelimab, Anti-Human HERV & RSV Envelope Protein Recombinant Antibody, GNbAC-1, GNbAC1, Antibody Drug Analogues, Monoclonal Antibody, YR1531, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1393641-34-3 |
Catalog # | YR1531 |
Price | please inquire |
Order / More Info | HERV & RSV Envelope Protein, Human (Temelimab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |